Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-035204
Filing Date
2020-12-28
Accepted
2020-12-28 16:30:40
Documents
1
Period of Report
2020-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4122
  Complete submission text file 0000899243-20-035204.txt   5471
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Gibson Neil W (Reporting) CIK: 0001555918 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39593 | Film No.: 201418681

Mailing Address 1018 W. 11TH STREET AUSTIN TX 78703
Business Address 1018 W. 11TH STREET AUSTIN TX 78703 919-864-2700
Shattuck Labs, Inc. (Issuer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations